KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Novavax (NVAX) Tax Provisions: 2010-2024

Historic Tax Provisions for Novavax (NVAX) over the last 7 years, with Dec 2024 value amounting to $10.9 million.

  • Novavax's Tax Provisions rose 36.34% to -$657,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $8.9 million, marking a year-over-year increase of 74.47%. This contributed to the annual value of $10.9 million for FY2024, which is 435.89% up from last year.
  • Latest data reveals that Novavax reported Tax Provisions of $10.9 million as of FY2024, which was up 435.89% from $2.0 million recorded in FY2023.
  • In the past 5 years, Novavax's Tax Provisions ranged from a high of $29.2 million in FY2021 and a low of $2.0 million during FY2023.
  • Its 3-year average for Tax Provisions is $5.7 million, with a median of $4.3 million in 2022.
  • In the last 5 years, Novavax's Tax Provisions slumped by 85.31% in 2022 and then surged by 435.89% in 2024.
  • Novavax's Tax Provisions (Yearly) stood at $29.2 million in 2021, then tumbled by 85.31% to $4.3 million in 2022, then plummeted by 52.68% to $2.0 million in 2023, then spiked by 435.89% to $10.9 million in 2024.